In a recent opinion piece, OB-GYN Christine Henneberg discusses the implications of restricting telehealth prescribing of mifepristone.
Henneberg argues that such restrictions would not necessarily end telehealth medication abortion, as alternative plans remain in place.
The ongoing debate highlights the need for accessible reproductive healthcare options in a changing regulatory environment.